| Tremfya (guselkumab) |
Tremfya IV, SC (guselkumab), Tremfya SC (guselkumab) |
| Tryngolza (olezarsen sodium) |
Tryngolza (olezarsen sodium) |
| Tukysa (tucatinib) |
Tukysa (tucatinib) |
| Turalio (pexidartinib) |
Turalio (pexidartinib) |
| Tykerb (lapatinib) |
Tykerb (lapatinib) |
| Ultomiris (ravulizumab-cwvz) |
Ultomiris (ravulizumab-cwvz) |
| Unituxin (dinutuximab) |
Unituxin (dinutuximab) |
| Urea Cycle Disorder Agents - PA, NF |
Buphenyl (sodium phenylbutyrate), Olpruva (sodium phenylbutyrate), Pheburane (sodium phenylbutyrate), Ravicti (glycerol phenylbutyrate) |
| Ustekinumab – PA, NF – Standard Default |
Stelara IV (ustekinumab), Imuldosa IV (ustekinumab-srlf), Otulfi IV (ustekinumab-aauz), Pyzchiva IV (ustekinumab-ttwe), Selarsdi IV (ustekinumab-aekn), Steqeyma IV (ustekinumab-stba), Wezlana IV (ustekinumab-auub), Yesintek IV (ustekinumab-kfce), Stelara SC (ustekinumab), Imuldosa SC (ustekinumab-srlf), Otulfi SC (ustekinumab-aauz), Pyzchiva SC (ustekinumab-ttwe), Selarsdi SC (ustekinumab-aekn), Steqeyma SC (ustekinumab-stba), Wezlana SC (ustekinumab-auub), Yesintek SC (ustekinumab-kfce) |
| Venclexta (venetoclax) |
Venclexta (venetoclax) |
| Veopoz (pozelimab-bbfg) |
Veopoz (pozelimab-bbfg) |
| Verzenio (abemaciclib) |
Verzenio (abemaciclib) |
| Vimizim (elosulfase alfa) |
Vimizim (elosulfase alfa) |
| Voranigo (Vorasidenib) |
Voranigo (Vorasidenib) |
| Votrient (pazopanib) |
Votrient (pazopanib) |
| Vyndaqel (tafamidis meglumine), Vyndamax (tafamidis) |
Vyndaqel (tafamidis meglumine), Vyndamax (tafamidis) |
| Vyxeos (daunorubicin and cytarabine) |
Vyxeos (daunorubicin and cytarabine) |
| Xalkori (crizotinib) - PA, NF |
Xalkori (crizotinib) |
| Xdemvy (lotilaner) PA, NF |
Xdemvy (lotilaner ophthalmic solution) |
| Xeljanz, Xeljanz XR (tofacitinib) |
Xeljanz (tofacitinib) tablets and oral solution, Xeljanz (tofacitinib) tablets, Xeljanz XR (tofacitinib) extended-release tablets |
HEALTHY LIVING